| Selective inhibition of BET bromodomains P Filippakopoulos, J Qi, S Picaud, Y Shen, WB Smith, O Fedorov, ... Nature 468 (7327), 1067-1073, 2010 | 4217 | 2010 |
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc JE Delmore, GC Issa, ME Lemieux, PB Rahl, J Shi, HM Jacobs, E Kastritis, ... Cell 146 (6), 904-917, 2011 | 3084 | 2011 |
| Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl E Weisberg, PW Manley, W Breitenstein, J Brüggen, SW Cowan-Jacob, ... Cancer cell 7 (2), 129-141, 2005 | 1923 | 2005 |
| Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix LD Walensky, AL Kung, I Escher, TJ Malia, S Barbuto, RD Wright, ... science 305 (5689), 1466-1470, 2004 | 1665 | 2004 |
| Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing C Kanellopoulou, SA Muljo, AL Kung, S Ganesan, R Drapkin, T Jenuwein, ... Genes & development 19 (4), 489-501, 2005 | 1597 | 2005 |
| Role of T-bet in commitment of TH1 cells before IL-12-dependent selection AC Mullen, FA High, AS Hutchins, HW Lee, AV Villarino, DM Livingston, ... Science 292 (5523), 1907-1910, 2001 | 1167 | 2001 |
| Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor SR Daigle, EJ Olhava, CA Therkelsen, CR Majer, CJ Sneeringer, J Song, ... Cancer cell 20 (1), 53-65, 2011 | 1001 | 2011 |
| MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L KM Bernt, N Zhu, AU Sinha, S Vempati, J Faber, AV Krivtsov, Z Feng, ... Cancer cell 20 (1), 66-78, 2011 | 944 | 2011 |
| Direct inhibition of the NOTCH transcription factor complex RE Moellering, M Cornejo, TN Davis, CD Bianco, JC Aster, SC Blacklow, ... Nature 462 (7270), 182-188, 2009 | 920 | 2009 |
| Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF R Haq, J Shoag, P Andreu-Perez, S Yokoyama, H Edelman, GC Rowe, ... Cancer cell 23 (3), 302-315, 2013 | 839 | 2013 |
| Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma B Chapuy, MR McKeown, CY Lin, S Monti, MGM Roemer, J Qi, PB Rahl, ... Cancer cell 24 (6), 777-790, 2013 | 814 | 2013 |
| Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors CS Mitsiades, NS Mitsiades, CJ McMullan, V Poulaki, R Shringarpure, ... Cancer cell 5 (3), 221-230, 2004 | 792 | 2004 |
| A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors JB Rubin, AL Kung, RS Klein, JA Chan, YP Sun, K Schmidt, MW Kieran, ... Proceedings of the National Academy of Sciences 100 (23), 13513-13518, 2003 | 735 | 2003 |
| Targeting MYCN in neuroblastoma by BET bromodomain inhibition A Puissant, SM Frumm, G Alexe, CF Bassil, J Qi, YH Chanthery, ... Cancer discovery 3 (3), 308-323, 2013 | 700 | 2013 |
| SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction H Inuzuka, S Shaik, I Onoyama, D Gao, A Tseng, RS Maser, B Zhai, ... Nature 471 (7336), 104-109, 2011 | 690 | 2011 |
| Suppression of tumor growth through disruption of hypoxia-inducible transcription AL Kung, S Wang, JM Klco, WG Kaelin, DM Livingston Nature medicine 6 (12), 1335-1340, 2000 | 690 | 2000 |
| Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma L Santo, T Hideshima, AL Kung, JC Tseng, D Tamang, M Yang, M Jarpe, ... Blood, The Journal of the American Society of Hematology 119 (11), 2579-2589, 2012 | 656 | 2012 |
| Polyubiquitination of p53 by a ubiquitin ligase activity of p300 SR Grossman, ME Deato, C Brignone, HM Chan, AL Kung, H Tagami, ... Science 300 (5617), 342-344, 2003 | 625 | 2003 |
| H3K79 methylation profiles define murine and human MLL-AF4 leukemias AV Krivtsov, Z Feng, ME Lemieux, J Faber, S Vempati, AU Sinha, X Xia, ... Cancer cell 14 (5), 355-368, 2008 | 617 | 2008 |
| Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway AL Kung, SD Zabludoff, DS France, SJ Freedman, EA Tanner, A Vieira, ... Cancer cell 6 (1), 33-43, 2004 | 613 | 2004 |
James BradnerNovartis Institutes for BioMedical ResearchVerified email at novartis.com
